Teladoc Health, Inc. (TDOC)

New York Stock Exchange:
TDOC
| Latest update: Nov 4, 2025, 1:31 PM

Stock events for Teladoc Health, Inc. (TDOC)

In April 2025, Teladoc Health reported its Q1 earnings, announced the acquisition of UpLift Health Technologies, and launched its next-generation Cardiometabolic Health Program; Q1 revenue increased, but total visits decreased. In July 2025, the company released its Q2 earnings, reporting an EPS that topped estimates and revenue exceeding expectations, while reaffirming its full-year outlook; Mizuho initiated coverage with a "neutral" rating, and the company launched the "Wellbound" employee assistance program. In October 2025, the CFO announced her departure, the company reaffirmed its full-year outlook, and preliminary Q3 results showed revenue slightly surpassing estimates and adjusted EBITDA exceeding expectations, despite a net loss; the stock saw an increase following these announcements, with analyst upgrades and increased price targets, though Weiss Ratings reiterated a "sell" rating; the company also launched a new AI-enabled workplace violence prevention capability.

Demand Seasonality affecting Teladoc Health, Inc.’s stock price

While there aren't explicit details of strong seasonal demand patterns, Teladoc Health's virtual visits have shown some fluctuations, remaining relatively stable above 4.5 million for six consecutive quarters as of August 2023. However, total visits slipped in Q1 2024, and the BetterHelp segment experienced a revenue drop in Q3 2024 due to lower user additions and a decline in average paying users, reflecting headwinds in the U.S. cash pay business and softening consumer sentiment. This indicates that specific segments can be influenced by market conditions and broader consumer behavior rather than distinct seasonal cycles.

Overview of Teladoc Health, Inc.’s business

Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company operating in the Health Care sector, specifically in Health Care Technology and Medical/Nursing Services. It connects patients with doctors and specialists through online platforms, using telephone, videoconferencing, and mobile apps for remote medical care. The company's major products and services are categorized into Teladoc Health Integrated Care and BetterHelp. The Integrated Care segment offers virtual medical services, including consultations, expert opinions, specialty care, chronic condition management, and mental health support, along with enabling technologies. The BetterHelp segment is a direct-to-consumer mental health platform offering online counseling and therapy. Teladoc Health generates revenue through subscription access fees and visit fees.

TDOC’s Geographic footprint

Teladoc Health, Inc. has a significant global presence, operating in over 130 countries across the Americas, Europe, and Asia-Pacific.

TDOC Corporate Image Assessment

Teladoc Health has been recognized on several Forbes lists, including "America's Best Employers For Company Culture (2025)", "America's Best Employers for Women (2025)", "America's Best Large Employers (2025)", and "America's Dream Employers (2025)". The company was also listed in "America's Best Employers for Diversity (2024)" and "Most Cybersecure Companies (2023)". However, the company's stock performance has led to some negative sentiment regarding its investment outlook, with concerns about whether Teladoc is a "Hidden Bargain or a Value Trap" and if its stock is "worth the hype". Renewed investor caution arose due to slow revenue growth, declining average revenue per user, and flat sales forecasts.

Ownership

Teladoc Health, Inc. is predominantly owned by institutional investors, who hold approximately 72.60% to 76.82% of the company's stock. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., Point72 Asset Management, L.P., Renaissance Technologies Llc, Dimensional Fund Advisors Lp, State Street Corp, and Geode Capital Management, Llc. HLM Venture Partners II LP is noted as the largest individual shareholder.

Expert AI

Show me the sentiment for Teladoc Health, Inc.
What's the latest sentiment for Teladoc Health, Inc.?

Price Chart

$8.14

9.66%
(1 month)

Top Shareholders

The Vanguard Group, Inc.
12.21%
BlackRock, Inc.
8.04%
Point72 Capital Holdings LP
5.01%
Renaissance Technologies Holdings Corp.
4.25%
Dimensional Holdings, Inc.
3.23%
State Street Corp.
2.89%
Geode Holdings Trust
2.41%
Wellington Management Group LLP
1.77%
Two Sigma Advisers LP
1.65%
Three Sisters Holdings, Inc.
1.56%
The Charles Schwab Corp.
1.53%
The Goldman Sachs Group, Inc.
1.51%
Two Sigma Investments LP
1.27%
Ameriprise Financial, Inc.
1.19%
Bodel, Inc.
1.16%
Morgan Stanley
1.14%
Northern Trust Corp.
1.06%
UBS Group AG
0.97%
Voloridge Holdings LP
0.97%
Woodline Partners Holdings LP
0.91%

Trade Ideas for TDOC

Today

Sentiment for TDOC

News
Social

Buzz Talk for TDOC

Today

Social Media

FAQ

What is the current stock price of Teladoc Health, Inc.?

As of the latest update, Teladoc Health, Inc.'s stock is trading at $8.14 per share.

What’s happening with Teladoc Health, Inc. stock today?

Today, Teladoc Health, Inc. stock is down by -9.66%, possibly due to news.

What is the market sentiment around Teladoc Health, Inc. stock?

Current sentiment around Teladoc Health, Inc. stock is negative, based on recent news, trading volume, and analyst opinions.

Is Teladoc Health, Inc.'s stock price growing?

Over the past month, Teladoc Health, Inc.'s stock price has decreased by -9.66%.

How can I buy Teladoc Health, Inc. stock?

You can buy Teladoc Health, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol TDOC

Who are the major shareholders of Teladoc Health, Inc. stock?

Major shareholders of Teladoc Health, Inc. include institutions such as The Vanguard Group, Inc. (12.21%), BlackRock, Inc. (8.04%), Point72 Capital Holdings LP (5.01%) ... , according to the latest filings.